[HTML][HTML] Prevalence of ten LRRK2 variants in Parkinson's disease: A comprehensive review

C Simpson, L Vinikoor-Imler, FL Nassan… - Parkinsonism & Related …, 2022 - Elsevier
Introduction Variants in the leucine-rich repeat kinase 2 gene (LRRK2) are risk factors for
Parkinson's disease (PD), but their prevalence varies geographically, reflecting the locations …

[HTML][HTML] Genetic testing of movements disorders: A review of clinical utility

D Yeow, LI Rudaks, SF Siow, RL Davis… - Tremor and Other …, 2024 - ncbi.nlm.nih.gov
Currently, pathogenic variants in more than 500 different genes are known to cause various
movement disorders. The increasing accessibility and reducing cost of genetic testing has …

l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease

K Raj, GD Gupta, S Singh - Drug and Chemical Toxicology, 2022 - Taylor & Francis
Parkinson's disease (PD) is the second most prevalent progressive neurodegenerative
disease, characterized by loss of dopaminergic neurons in substantia nigra, with deficiency …